Kenvue
KVUE----
Kenvue (KVUE)
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin Amer...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Kenvue Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$19.832.87%
Forecast & RatingHold
14analysts
- Strong buy7.14%
- Buy7.14%
- Hold85.71%
- Sell0.00%
- Strong sell0.00%
News
- MarketWatch Automated · 10 hours ago
Kenvue Inc. Stock Rises Friday, Outperforms Market
- prnewswire · 13 hours ago
14:00 ETFDA Approves TYLENOL® with Naproxen, the First and Only Over-the-Counter Fixed-Dose Combination of Acetaminophen (650 mg) and Naproxen Sodium (220 mg)
- Market Beat · 20 hours ago
Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE
- Global Report · 21 hours ago
Diverging Signals: How Aerospace, Consumer, and Tech Firms Are Navigating the 2026 Landscape
- MarketWatch Automated · 1 day ago, 03:55 PM
Kenvue Inc. Stock Falls Thursday, Still Outperforms Market
- Unusual Whales · 1 day ago, 05:54 AM
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
